RELMADA THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period
RELMADA THERAPEUTICS, INC. (RLMD) reported Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period of 487.43 thousand shares for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod · last filed 2025-03-27
- RELMADA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, shares issued in period for fiscal 2024 was 487.43K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period 2 month | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period 12 month |
|---|---|---|---|
| 2024-12-31 | 487.43K shares 10-K · filed 2025-03-27 | ||
| 2023-12-15 | 5.01M shares 10-K · filed 2025-03-27 | ||
| 2023-09-18 | 10.00K shares 10-K · filed 2025-03-27 | ||
| 2023-06-20 | 60.00K shares 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |